Article

Medicare pushes for preventive treatments, payments increase

Washington, DC-The Centers for Medicare & Medicaid Services (CMS) is proposing new benefits to help beneficiaries gain access to preventive services and an across-the-board 1.5% increase in payment rates to physicians caring for them.

Washington, DC-The Centers for Medicare & Medicaid Services (CMS) is proposing new benefits to help beneficiaries gain access to preventive services and an across-the-board 1.5% increase in payment rates to physicians caring for them.

The new payments are part of the Physician Fee Schedule for 2005.

The proposal to increase benefits is geared to promote a more modern prevention-based system. It includes a physical for all new Medicare beneficiaries who will receive a variety of screenings and a plan to increase Medicare payments for new drugs, saving beneficiaries about $270 million.

Medicare will increase its spending for more than 875,000 physicians and other health-care professionals by more than 4% from a projected $52.7 billion in 2004 to about $55 billion in 2005. The payment calls for a 1.5% increase in 2004 and 2005, avoiding a projected update of -3.7% for 2005 under previous law.

Comments on the proposals, which were published in the Aug. 5 Federal Register, will be accepted until Sept. 24.

The final rule is expected by Nov. 1 and would take effect Jan. 1.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.